| Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines A Rinaldi, R Caraffi, MV Grazioli, N Oddone, L Giardino, G Tosi, ... Polymers 14 (4), 687, 2022 | 43 | 2022 |
| Tunneling nanotubes: a new target for nanomedicine? I Ottonelli, R Caraffi, G Tosi, MA Vandelli, JT Duskey, B Ruozi International Journal of Molecular Sciences 23 (4), 2237, 2022 | 17 | 2022 |
| Optimization of an injectable hydrogel depot system for the controlled release of retinal-targeted hybrid nanoparticles I Ottonelli, A Bighinati, E Adani, F Loll, R Caraffi, MA Vandelli, F Boury, ... Pharmaceutics 15 (1), 25, 2022 | 14 | 2022 |
| Glioblastoma multiforme selective nanomedicines for improved anti-cancer treatments JT Duskey, A Rinaldi, I Ottonelli, R Caraffi, CA De Benedictis, AK Sauer, ... Pharmaceutics 14 (7), 1450, 2022 | 10 | 2022 |
| Quantitative comparison of the protein corona of nanoparticles with different matrices I Ottonelli, JT Duskey, F Genovese, F Pederzoli, R Caraffi, M Valenza, ... International Journal of Pharmaceutics: X 4, 100136, 2022 | 8 | 2022 |
| Recent advances on surface-modified GBM targeted nanoparticles: targeting strategies and surface characterization F Rodà, R Caraffi, S Picciolini, G Tosi, MA Vandelli, B Ruozi, M Bedoni, ... International Journal of Molecular Sciences 24 (3), 2496, 2023 | 6 | 2023 |
| The key role of public health in renovating Italian biomedical doctoral programs. L Palandri, T Urbano, C Pezzuoli, F Miselli, R Caraffi, T Filippini, ... Annali di Igiene, Medicina Preventiva e di Comunità 36 (3), 2024 | 3 | 2024 |
| Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease G Birolini, M Valenza, I Ottonelli, F Talpo, L Minoli, A Cappelleri, ... Pharmacological Research 194, 106823, 2023 | 3 | 2023 |
| “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury M Moretti, R Caraffi, L Lorenzini, I Ottonelli, M Sannia, G Alastra, ... Cells 12 (9), 1331, 2023 | 2 | 2023 |
| I17 Sustained benefits of brain-permeable cholesterol-loaded nanoparticles in zQ175DN mouse model M Valenza, G Birolini, I Ottonelli, F Talpo, A Passoni, M Favagrossa, ... Journal of Neurology, Neurosurgery and Psychiatry 93 (Suppl 1), A90-A90, 2022 | 1 | 2022 |
| Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease G Birolini, M Valenza, O Ilaria, T Francesca, L Minoli, A Cappelleri, ... | 1 | 2022 |
| Challenges of enzyme therapy: Why two players are better than one S Cuoghi, R Caraffi, A Anderlini, C Baraldi, E Enzo, MA Vandelli, G Tosi, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 16 (4 …, 2024 | | 2024 |
| Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices”[Int J Pharm X 2022 Oct 21; 4: 100136] I Ottonelli, JT Duskey, F Genovese, F Pederzoli, R Caraffi, M Valenza, ... International Journal of Pharmaceutics: X 5, 2023 | | 2023 |
| Sviluppo di nuove nanoparticelle per l'attraversamento della BEE: studio preformulativo con loperamide come farmaco modello R CARAFFI | | 2021 |
| P52–OPTIMING TEMOZOLOMIDE LOADING INTO HYBRID PLGA-CHOLESTEROL NANOPARTICLES FOR GLIOBLASTOMA MULTIFORME TREATMENT A Rinaldi, JT Duskey, R Caraffi, G Tosi, M Angela Book of abstract, 77, 0 | | |
